Literature DB >> 17705188

The membrane protein of SARS-CoV suppresses NF-kappaB activation.

Xiaonan Fang1, Jinrong Gao, Hong Zheng, Baozong Li, Lingbao Kong, Yijuan Zhang, Wei Wang, Yingchun Zeng, Linbai Ye.   

Abstract

Severe acute respiratory syndrome coronavirus (SARS-CoV) infects many organs, such as lung, liver, and immune organs and causes life-threatening atypical pneumonia, SARS causes high morbidity and mortality rates. The molecular mechanism of SARS pathogenesis remains elusive. Inflammatory stimuli can activate IkappaB kinase (IKK) signalsome and subsequently the nuclear factor kappa B (NF-kappaB), which influences gene expression of cyclooxygenase-2 (Cox-2) along with other transcription factors. In this work, we found that the membrane (M) protein of SARS-CoV physically interacted with IKKbeta using a co-immunoprecipitation assay (IPA). Expression of M suppressed tumor necrosis factor alpha (TNF-alpha) induced NF-kappaB activation using a luciferase reporter assay. Further investigation showed M protein suppressed Cox-2 expression using a luciferase reporter gene assay, RT-PCR and Western blot analysis. The carboxyl terminal of M protein was sufficient for the M protein function. Together, these results indicate that SARS-CoV M suppresses NF-kappaB activity probably through a direct interaction with IKKbeta, resulting in lower Cox-2 expression. Suppression of NF-kappaB activity and Cox-2 expression may contribute to SARS pathogenesis. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17705188      PMCID: PMC7166727          DOI: 10.1002/jmv.20953

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  43 in total

1.  Assembly of the coronavirus envelope: homotypic interactions between the M proteins.

Authors:  C A de Haan; H Vennema; P J Rottier
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

Review 2.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 3.  Cyclooxygenase-2: a therapeutic target.

Authors:  Marco E Turini; Raymond N DuBois
Journal:  Annu Rev Med       Date:  2002       Impact factor: 13.739

4.  Peptidoglycan induces nuclear factor-kappaB activation and cyclooxygenase-2 expression via Ras, Raf-1, and ERK in RAW 264.7 macrophages.

Authors:  Bing-Chang Chen; Ya-Sheng Chang; Ju-Chiun Kang; Ming-Jen Hsu; Joen-Rong Sheu; Ta-Liang Chen; Che-Ming Teng; Chien-Huang Lin
Journal:  J Biol Chem       Date:  2004-03-08       Impact factor: 5.157

5.  A major outbreak of severe acute respiratory syndrome in Hong Kong.

Authors:  Nelson Lee; David Hui; Alan Wu; Paul Chan; Peter Cameron; Gavin M Joynt; Anil Ahuja; Man Yee Yung; C B Leung; K F To; S F Lui; C C Szeto; Sydney Chung; Joseph J Y Sung
Journal:  N Engl J Med       Date:  2003-04-07       Impact factor: 91.245

Review 6.  Cyclooxygenase in biology and disease.

Authors:  R N Dubois; S B Abramson; L Crofford; R A Gupta; L S Simon; L B Van De Putte; P E Lipsky
Journal:  FASEB J       Date:  1998-09       Impact factor: 5.191

7.  Peptide domain involved in the interaction between membrane protein and nucleocapsid protein of SARS-associated coronavirus.

Authors:  Xiaonan Fang; Linbai Ye; Khalid Amine Timani; Shanshan Li; Yingchun Zen; Meng Zhao; Hong Zheng; Zhenghui Wu
Journal:  J Biochem Mol Biol       Date:  2005-07-31

8.  EBV suppresses prostaglandin E2 biosynthesis in human monocytes.

Authors:  M Savard; C Bélanger; M J Tremblay; N Dumais; L Flamand; P Borgeat; J Gosselin
Journal:  J Immunol       Date:  2000-06-15       Impact factor: 5.422

9.  Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication.

Authors:  Hua Zhu; Jian-Ping Cong; Deborah Yu; Wade A Bresnahan; Thomas E Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

10.  Mice lacking the transcription factor subunit Rel can clear an influenza infection and have functional anti-viral cytotoxic T cells but do not develop an optimal antibody response.

Authors:  L Harling-McNabb; G Deliyannis; D C Jackson; S Gerondakis; G Grigoriadis; L E Brown
Journal:  Int Immunol       Date:  1999-09       Impact factor: 4.823

View more
  41 in total

1.  Quantitative proteomics using stable isotope labeling with amino acids in cell culture reveals changes in the cytoplasmic, nuclear, and nucleolar proteomes in Vero cells infected with the coronavirus infectious bronchitis virus.

Authors:  Edward Emmott; Mark A Rodgers; Andrew Macdonald; Sarah McCrory; Paul Ajuh; Julian A Hiscox
Journal:  Mol Cell Proteomics       Date:  2010-05-13       Impact factor: 5.911

2.  Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapy.

Authors:  Dale L Barnard; Yohichi Kumaki
Journal:  Future Virol       Date:  2011-05       Impact factor: 1.831

3.  SARS-CoV-2, Zika viruses and mycoplasma: Structure, pathogenesis and some treatment options in these emerging viral and bacterial infectious diseases.

Authors:  Gonzalo Ferreira; Axel Santander; Florencia Savio; Mariana Guirado; Luis Sobrevia; Garth L Nicolson
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-09-03       Impact factor: 5.187

4.  Exacerbated innate host response to SARS-CoV in aged non-human primates.

Authors:  Saskia L Smits; Anna de Lang; Judith M A van den Brand; Lonneke M Leijten; Wilfred F van IJcken; Marinus J C Eijkemans; Geert van Amerongen; Thijs Kuiken; Arno C Andeweg; Albert D M E Osterhaus; Bart L Haagmans
Journal:  PLoS Pathog       Date:  2010-02-05       Impact factor: 6.823

5.  Human coronavirus OC43 nucleocapsid protein binds microRNA 9 and potentiates NF-κB activation.

Authors:  Frances W Lai; Kyle B Stephenson; James Mahony; Brian D Lichty
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

6.  SARS-CoV-2 Membrane Protein Inhibits Type I Interferon Production Through Ubiquitin-Mediated Degradation of TBK1.

Authors:  Liyan Sui; Yinghua Zhao; Wenfang Wang; Ping Wu; Zedong Wang; Yang Yu; Zhijun Hou; Guangyun Tan; Quan Liu
Journal:  Front Immunol       Date:  2021-05-18       Impact factor: 7.561

Review 7.  Modulation of NF-κB signalling by microbial pathogens.

Authors:  Masmudur M Rahman; Grant McFadden
Journal:  Nat Rev Microbiol       Date:  2011-03-08       Impact factor: 60.633

8.  Identification of residues of SARS-CoV nsp1 that differentially affect inhibition of gene expression and antiviral signaling.

Authors:  Andrew R Jauregui; Dhruti Savalia; Virginia K Lowry; Cara M Farrell; Marc G Wathelet
Journal:  PLoS One       Date:  2013-04-29       Impact factor: 3.240

9.  Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3.TANK.TBK1/IKKepsilon complex.

Authors:  Kam-Leung Siu; Kin-Hang Kok; Ming-Him James Ng; Vincent K M Poon; Kwok-Yung Yuen; Bo-Jian Zheng; Dong-Yan Jin
Journal:  J Biol Chem       Date:  2009-04-20       Impact factor: 5.157

10.  Activation of NF-κB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2.

Authors:  Chia-Ming Su; Leyi Wang; Dongwan Yoo
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.